CTOR Financial Analysis

Citius Oncology Inc

CTOR

Citius Oncology Inc

0.664

-0.026(-3.770%)

Quarterly

	FY2025Q1	FY2024Q4	FY2024Q4	FY2024Q3	FY2024Q2	FY2024Q1	FY2023Q4	FY2023Q3	FY2023Q2	FY2023Q1	FY2022Q4

Net Cash Flow from Operating Activities	0.00 -100.00%	684.15K -412.72%	684.15K -412.72%	-366.11K 222.64%	-366.11K 265.17%	-191.69K 13.56%	-218.78K 356.09%	-113.47K	-100.26K	-168.80K	-47.97K
Funds from Operations	-4.59M 1608.64%	-12.42M 4987.90%	-12.42M 4987.90%	-383.96K -8.90%	-383.96K 92.41%	-268.43K 81.47%	-244.14K 117.58%	-421.46K	-199.55K	-147.92K	-112.21K
Change in Working Capital	4.59M 5876.74%	13.11M 51574.52%	13.11M 51574.52%	17.85K -94.20%	17.85K -82.02%	76.74K -467.58%	25.36K -60.52%	307.98K	99.30K	-20.88K	64.24K
Net Cash Flow from Investing Activities	0.00 -100.00%	-29.81M 4416.28%	-29.81M 4416.28%	68.64K -110.40%	68.64K	24.74M	-660.00K -99.02%	-660.00K	0.00	0.00	-67.32M
Net Cash Flow from Financing Activities	0.00 -100.00%	29.16M 3194.45%	29.16M 3194.45%	264.39K -38.50%	264.39K -24.45%	-24.55M	885.00K -98.69%	429.90K	349.98K	0.00	67.66M
Stock - Total - Issuance/(Retirement) - Net	0.00 -100.00%	0.00	0.00	-268.65K	-268.65K	-24.94M	0.00 -100.00%	0.00	0.00	0.00	66.03M
Debt - LT & ST - Issuance/(Retirement)	0.00 -100.00%	28.08M 2027.44%	28.08M 2027.44%	725.31K	325.31K	200.00K	1.32M -1110.05%	0.00	0.00	0.00	-130.69K
Net Change in Cash	0.00 -100.00%	32.60K 423.81%	32.60K 423.81%	-33.07K -90.37%	-33.07K -113.24%	584.00 -100.35%	6.22K -97.85%	-343.57K	249.72K	-168.80K	289.18K
Free Cash Flow	0.00 -100.00%	684.15K -412.72%	684.15K -412.72%	-366.11K 222.64%	-366.11K	-191.69K	-218.78K 356.09%	-113.47K	0.00	0.00	-47.97K

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

CTOR FAQs

CTOR's PE ratio in April 4, 2025 is -2.07. This indicates the price investors are willing to pay for $1 of earnings.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly